Investigating neural stem cell plasticity in the hippocampal niche, we demonstrate that retroviral forced expression of Mash1 (Mammalian Achaete-Scute Homolog 1), Olig1 (Oligodendrocyte transcription factor 1), and Olig2 (Oligodendrocyte transcription factor 2) genes, transcription factors involved in enhanced oligodendrogenesis, can contribute to directing the differentiation of adult subventricular zone neural stem cells to functional oligodendrocytes. We found that Mash1, Olig1 and Olig2 all induced oligodendrocyte differentiation. However, Olig1 and Olig2 induction resulted in an elevated number of generated oligodendrocytes without a significant production of other cell lineages, unlike Mash1. These newly differentiated cells are also capable of migration and possible myelination, showing that targeting oligodendrocyte production and possible remyelination is a viable therapeutic strategy for restoration of neuronal function.
INTRODUCTION
Identifying signaling and pathways that govern oligodendrocyte production would allow for the generation of a surplus of oligodendrocyte cells that are impervious from immune rejection and could be used as a therapeutic measure in diseases such as Multiple Sclerosis (MS) where myelination is compromised. In order to ensure the generation of sufficient number of oligodendrocytes needed for effective cell therapy, it would be advantageous to learn how these cells are derived from redirected granule cell precursors and whether induction of transcription factors involved in oligodendrocyte differentiation would improve the number of differentiated oligodendrocytes ( [1] Raff et al., 1998, [2] Raff et al., 2001 , [3] Stemple et al., 1992) .
In this study, we investigated neural stem cell plasticity in the hippocampal niche resulting in neuronal repair using a retroviral induction approach of multiple transcription factors to direct NSCs differentiation into oligodendrocytes in an inflammatory microenvironment analogous to that in MS [4] (Navikas et al., 1996). Our intent was to produce a sizeable number of oligodendrocytes from mouse hippocampal neural stem cells in Experimental Autoimmune Encephalomyelitis (EAE) disease model, widely used to study pathogenesis of autoimmunity, demyelination, cell trafficking, and tolerance induction [5] (Olsson et al., 1995) .
MATERIALS AND METHODS

Cell Culture
Forebrains were removed from15-day old mouse fetuses, mechanically dissociated then digested in 0.05% trypsin (Mediatech, Manassas, VA) for 15 min at 37˚, then washed with 1× DPBS (Mediatech, Manassas, VA) and passed gently through a 70 μm mesh. The cells were then centrifuged then the pellet was resuspended in DMEM/ 10% FBS/0.28% BSA. 14 mm diameter glass coverslips were coated with poly L-lysine (Sigma, St. Louis, MO) and placed in 24 well plates (CellstarOne, Monroe, North Carolina). The cells were plated at 5 × 104 cells per coverslip in 10 μl of media then placed at 37˚ with 5% CO 2 for 30 minutes to allow attachment. 500 μl of culture medium was added to each well for 2 weeks, media was replaced twice a week [6] (C. Lubetzki et al., 1993 ).
Generation of EAE Mice
C57B/6, both male and female, age 10 weeks old, were purchased from Taconic (Hudson, NY) and acclimated to our vivarium. EAE was induced via injections of a commercially available kit from Hooke's Laboratories (San Diego, CA, kit # EK-0115 (MOG 35-55/CFA Emulsion PTX). This was used according to manufactures protocol. The mice were monitored daily for changes (trembling, limping, partial or full paralysis, and other signs of EAE induction) and were scored using Hooke's scale of 0 -5. Using this system we were able to induce EAE as defined by 24-hour partial paralysis in greater than 70% of the mice within 14 days of the final injection of pertussis toxin. All mouse studies were done with IACUC approval with minimal discomfort to animals.
Retroviral Production
The GFP, Mash1, Shh, and Olig1 and Olig2 virus particles were made by cloning each gene into the AP2-GFP retrovirus plasmid via the Xho1 cut site. 293-GPG cells, grown in DMEM media with 10% FBS and 200 ug/ml G418, were used to obtain the retrovirus conditioned medium. These cells were transfected with each retrovirus construct using Invitrogen Lipofectamine 2000 Transfection Reagent (Invitrogen, Carlsbad, CA). The conditioned medium was taken every 24 hours. The medium was then concentrated using the ViraBind Retrovirus Concentration and Purification Kit Item #VPK-131 (Cell Biolabs Inc., San Diego, CA) as protocol required to obtain concentrated virus at <10'5 CFU.
Stereotactic Virus Injections
Mice were injected with Avertin at a concentration of 250 mg/kg to anesthetize the mice. Then each mouse was stereotactically injected using a Lab Standard Stereotaxic Instrument with Stoelting manual Stereotaxic injector (Stoelting, Wood Dale, IL) at -2 anterior/posterior +1.5 medial/laeral and -2.3 dorsal/ventral from the skull with concentrated virus.
Histological Preparation of Sections
Mice were then euthanized via a CO 2 chamber and brains and spinal cord taken for sectioning. Tissue was fixed in 4% paraformaldehyde prior to sectioning. The specimens were processed using a Leica TP1020 Automated Tissue Processor and a Fisher HistoCenter embedding station, then sectioned at 5 μm with a Microm microtome.
Immunohistochemistry
Histological and cell culture sections were performed as previously described in our lab [6] 
RESULTS
In Vitro Induction of Oligodendrocyte Differentiation
We focused on transcription factors that have been shown regulate oligodendrocyte differentiation from NSCs (Figure 1(a) (Figure 1(b) ) on isolated mouse neural stem cells in culture to analyze their effects on the oligodendrocyte development using previously established methods [15] (C. Lubetzki et al., 1993) . We found that Olig2 had the greatest effect on oligodendrocyte differentiation and these newly generated oligodendrocytes were making an effort to myelinate the axons of neurons in cell culture (Figures 2A-F) . We demonstrate that NSCs induced with Olig2 retrovirus (Figure 2A ) differentiate into oligodendrocytes ( Figure 2B ) which migrate toward neurons ( Figure 2C ) and initiate myelination (Figures 2E and F) . We found that both Olig1 and Olig2 induced oligodendrocyte differentiation, however, Olig2 induction resulted in a higher and more consistent average of generated oligodendrocytes ( Figure 2G ). We did not observe a significant synergistic effect of Olig1 and Olig2 induction ( Figure 2G ). Mash1 and Shh unlike Olig1 and Olig2 produced a small number of oligodendrocytes when induced alone or in combination ( Figure  2G) . Interestingly, induction of NSCs with combinations of Mash1 or Shh with Olig1 or Olig2 caused a decrease in oligodendrocyte differentiation as compared to Olig1 or Olig2 alone ( Figure 2G ).
In Vivo Induction of Oligodendrocyte Differentiation
We examined forced retroviral expression of Mash1, Olig1, or Olig-AP2 in differentiating subventricular zone neural stem cells and its effect on oligodendrocyte fate in an inflammatory enriched microenvironment, we examined EAE C57B/6 mice that underwent concentrated retrovirus particles (<10'5 CFU) injections in the subventricular zone, following a previously published protocol ( [14] Jessberger et al., 2009). At week four, we examined histological sections of the brain to evaluate retrovirally induced cell differentiation to oligodendrogenic, neuronal, and glial lineages using specific lineage markers. Mash1 differentiate stem cells to oligodendrocytes upon viral induction, but concomitantly we found a proliferation of virally induced neurons and astrocytes ( Figures 3A-C Figure 3D ) and Olig2 ( Figure 3G ) induction resulted in a significant increase of differentiated oligodendrocytes as compared to Mash1. In contrast to Mash1, cells from neuron and astrocyte lineages were not abundant in either Olig1 or Olig2 induction ( Figures 3E, F, H, I ). These findings, when compared to the GFP-AP2 virus control, suggest that Olig1 and Olig2 induction results in an increased population of differentiated oligodendrocytes without a significant production of other cell lineages ( Figure 3J ).
Oligodendrocytes Derived from SVZ Progenitors Possibly Myelinate and Migrate to Spinal Cord
We next examined whether differentiated oligodendrocytes from the SVZ in EAE mice would myelinate neurons or migrate within the central nervous system. We observed that Mash1, Olig1, and Olig2-AP2 viral expressing oligodendrocytes were abundant and close to neurons detected with antibody for neurofilament protein NF with the prospective to myelinate (Figures 4A-C) . These newly differentiated stem cells show great potential in their ability to function as mature oligodendrocytes in an adult mouse model by making contact with nearby neurons. Using a specific marker for oligodendrocytes (RIP) we investigated these differentiated oligodendrocytes migrating a distance of several centimeters within the central nervous system of EAE induced C56B/6 mice. To show their migrating ability, we analyzed spinal cord sections up to 3 cm down each spine and found that virus induced differentiated oligodendrocytes were observed to have migrated the entire length of these sections (Figures 5A-C) , giving support to the plasticity of adult mouse neural stem cells. These observations along with the significant increase in oligodendrocyte production from SVZ-derived cells in the brain injured by EAE provide additional evidence that predominatly Olig1 and Olig2 expression in SVZ cells directs them to a mature oligodendrocyte fate.
DISCUSSION
We have demonstrated that retroviral forced expression of Mash1, Olig1, and Olig2 genes, involved in enhanced oligodendrogenesis, can contribute to directing the differentiation of adult subventricular zone neural stem cells to functional oligodendrocytes. Mash1 alone or with Shh produced oligodendrocytes, but it was Olig1 and Olig2 that gave us a much larger increase in oligodendrocyte numbers while creating fewer cells from the neuronal lineage. These oligodendrocytes are also capable of migration and possible myelination. These findings could allow us to design small molecules that would be used to force ones own neural stem cells to make oligodendrocytes and remyelinate the damaged axons and consequently restore neuronal function. These reports show that targeting oligodendrocyte production and possible remylination is a viable therapeutic strategy for restoration of neuronal function. We envision that results of the proposed study may extend to several neurological disorders where cellular replacement is needed. Future work should be done to find whether all the oligodendrocytes formed are mature enough to partake in full remyelination of axons that have loss of function due to EAE.
